BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27816300)

  • 1. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
    JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
    Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
    Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
    JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Outcomes After Localized Prostate Cancer Treatment.
    Al Hussein Al Awamlh B; Wallis CJD; Penson DF; Huang LC; Zhao Z; Conwill R; Talwar R; Morgans AK; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; O'Neil BB; Koyama T; Hoffman KE; Barocas DA
    JAMA; 2024 Jan; 331(4):302-317. PubMed ID: 38261043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
    Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
    Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
    Chen RC; Basak R; Meyer AM; Kuo TM; Carpenter WR; Agans RP; Broughman JR; Reeve BB; Nielsen ME; Usinger DS; Spearman KC; Walden S; Kaleel D; Anderson M; Stürmer T; Godley PA
    JAMA; 2017 Mar; 317(11):1141-1150. PubMed ID: 28324092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer.
    Johnson TK; Gilliland FD; Hoffman RM; Deapen D; Penson DF; Stanford JL; Albertsen PC; Hamilton AS
    J Clin Oncol; 2004 Oct; 22(20):4193-201. PubMed ID: 15483030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
    Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
    Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study.
    Reisz PA; Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    J Urol; 2020 Dec; 204(6):1236-1241. PubMed ID: 32568605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
    Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
    Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
    De B; Pasalic D; Barocas DA; Wallis CJD; Huang LC; Zhao Z; Koyama T; Tang C; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Hoffman KE
    J Urol; 2022 Dec; 208(6):1226-1239. PubMed ID: 36006050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Koyama T; Albertsen PC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Hoffman RM; Kaplan SH; McCollum D; Paddock LE; Stanford JL; Stroup AM; Wu XC; Penson DF
    Eur Urol; 2015 Jun; 67(6):1019-1025. PubMed ID: 25174325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
    Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
    Wallis CJD; Huang LC; Zhao Z; Penson DF; Koyama T; Conwill R; Tallman JE; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Barocas DA; Hoffman KE
    Urol Oncol; 2022 Feb; 40(2):56.e1-56.e8. PubMed ID: 34154899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
    Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
    Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.